BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34843387)

  • 21. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
    Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Royo-Cebrecos C; Laporte-Amargós J; Peña M; Ruiz-Camps I; Puerta-Alcalde P; Abdala E; Oltolini C; Akova M; Montejo M; Mikulska M; Martín-Dávila P; Herrera F; Gasch O; Drgona L; Morales HMP; Brunel AS; García E; Isler B; Kern WV; Palacios-Baena ZR; de la Calle GM; Montero MM; Kanj SS; Sipahi OR; Calik S; Márquez-Gómez I; Marin JI; Gomes MZR; Hemmatti P; Araos R; Peghin M; Del Pozo JL; Yáñez L; Tilley R; Manzur A; Novo A; Carratalà J; Gudiol C;
    Pathogens; 2022 Sep; 11(10):. PubMed ID: 36297188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay.
    Shorr AF; Micek ST; Welch EC; Doherty JA; Reichley RM; Kollef MH
    Crit Care Med; 2011 Jan; 39(1):46-51. PubMed ID: 20890186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of shock and mortality in solid organ transplant recipients with bacteremia caused by non-lactose-fermenting gram-negative bacilli.
    Wan Q; Luo A; Ye Q; Liu S; Zhou J
    Infect Dis (Lond); 2016; 48(1):32-9. PubMed ID: 26329287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-course aminoglycosides as adjunctive empirical therapy in patients with Gram-negative bloodstream infection, a cohort study.
    Deelen JWT; Rottier WC; Buiting AGM; Dorigo-Zetsma JW; Kluytmans JAJW; van der Linden PD; Thijsen SFT; Vlaminckx BJM; Weersink AJL; Ammerlaan HSM; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2021 Feb; 27(2):269-275. PubMed ID: 32387438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Septic shock in patients with blood diseases. Analysis of clinical situation, treatment and outcome in sixty patients].
    Waszczuk-Gajda A; Krzyścin M; Kamiński M; Snarski E; Wiktor-Jedrzejczak W
    Pol Arch Med Wewn; 2006 Apr; 115(4):336-44. PubMed ID: 17078492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study.
    de la Court JR; Heijmans J; Huynh J; Sieswerda E; de Jonge NA; van Dijk K; Sigaloff KCE; Schade RP
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):160. PubMed ID: 36529742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
    Giannella M; Pascale R; Ferraro G; Toschi A; Pancaldi L; Furii F; Bartoletti M; Tedeschi S; Ambretti S; Lewis RE; Viale P
    Int J Antimicrob Agents; 2019 May; 53(5):574-581. PubMed ID: 30639527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study.
    Zilberberg MD; Shorr AF; Micek ST; Vazquez-Guillamet C; Kollef MH
    Crit Care; 2014 Nov; 18(6):596. PubMed ID: 25412897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.
    Alrstom A; Alsuliman T; Daher N; Abouharb R
    Infect Chemother; 2021 Mar; 53(1):63-74. PubMed ID: 33538132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study.
    Ong DSY; Frencken JF; Klein Klouwenberg PMC; Juffermans N; van der Poll T; Bonten MJM; Cremer OL;
    Clin Infect Dis; 2017 Jun; 64(12):1731-1736. PubMed ID: 28329088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment*.
    Labelle A; Juang P; Reichley R; Micek S; Hoffmann J; Hoban A; Hampton N; Kollef M
    Crit Care Med; 2012 Jul; 40(7):2016-21. PubMed ID: 22584765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and risk factors for recurrence in biliary source bloodstream infection episodes in oncological patients.
    Grafia I; Chumbita M; Seguí E; Cardozo C; Laguna JC; García de Herreros M; Garcia-Pouton N; Villaescusa A; Pitart C; Rico-Caballero V; Marco-Hernández J; Zamora C; Viladot M; Padrosa J; Tuca A; Mayor-Vázquez E; Marco F; Martínez JA; Mensa J; Garcia-Vidal C; Soriano A; Puerta-Alcalde P
    Microbiol Spectr; 2023 Aug; 11(5):e0214223. PubMed ID: 37610217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empiric combination therapy for gram-negative bacteremia.
    Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
    Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.
    Yoon YK; Park DW; Sohn JW; Kim HY; Kim YS; Lee CS; Lee MS; Ryu SY; Jang HC; Choi YJ; Kang CI; Choi HJ; Lee SS; Kim SW; Kim SI; Kim ES; Kim JY; Yang KS; Peck KR; Kim MJ
    BMC Infect Dis; 2016 Jul; 16():331. PubMed ID: 27418274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance.
    Lee NH; Kang JM; Lee JW; Huh HJ; Lee NY; Yoo KH; Sung KW; Koo HH; Kim YJ
    Pediatr Infect Dis J; 2020 Oct; 39(10):931-936. PubMed ID: 32453199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
    Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Corcia-Palomo Y; Fernández-Delgado E; Herrera-Melero I; Ortiz-Leyba C; Márquez-Vácaro JA
    Intensive Care Med; 2014 Jan; 40(1):32-40. PubMed ID: 24026297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study.
    Wisplinghoff H; Cornely OA; Moser S; Bethe U; Stützer H; Salzberger B; Fätkenheuer G; Seifert H
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):905-11. PubMed ID: 14700405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective antibiotic treatment prescribed by emergency physicians in patients admitted to the intensive care unit with severe sepsis or septic shock: where is the gap?
    Capp R; Chang Y; Brown DF
    J Emerg Med; 2011 Dec; 41(6):573-80. PubMed ID: 21371846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
    Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.